Burning Rock Biotech (BNR) Assets Average (2020 - 2026)

Burning Rock Biotech's Assets Average history runs 7 years deep, the most recent figure standing at $114.9 million for Q1 2026.

• In Q1 2026, Assets Average fell 4.63% year-over-year to $114.9 million; the TTM figure through Mar 2026 stood at $114.9 million (down 4.63% YoY), while the FY2025 annual figure was $119.3 million, down 10.89% from the prior year.
• Assets Average for Q1 2026 stood at $114.9 million, roughly flat from $114.9 million in the prior quarter.
• The five-year high for Assets Average was $344.4 million in Q1 2022, with the low at $114.6 million in Q3 2025.
• The 5-year median for Assets Average is $140.6 million (2024), against an average of $177.1 million.
• The sharpest annual moves came in 2023 and 2026: Assets Average tumbled 37.64% in 2023, then retreated 4.63% in 2026.
• Burning Rock Biotech's Assets Average stood at $233.3 million in 2022, then plunged by 34.77% to $152.2 million in 2023, then retreated by 13.4% to $131.8 million in 2024, then dropped by 12.83% to $114.9 million in 2025, then rose by 0.05% to $114.9 million in 2026.
• Business Quant data shows BNR's Assets Average at $114.9 million in Q1 2026, $114.9 million in Q4 2025, and $114.6 million in Q3 2025.